ENGINEERED RELAXINS AND METHODS OF USE THEREOF

Title:

ENGINEERED RELAXINS AND METHODS OF USE THEREOF

Document Type and Number:

WIPO Patent Application WO/2021/226439

Kind Code:

A3

Abstract:

The present invention provides novel recombinant relaxin-2 compositions and methods for making the same. Also disclosed herein are methods of treating relaxin-2-associated disorders or diseases using the compositions of the invention.

More Like This:

JPS62294432	RIBOSOME USING PHOSPHATIDE AS BASE AND MEDICINE COMPOSITION
JP2016516669	Compositions and Methods for Inhibiting Tumor Cells by Inhibiting the Transcription Factor ATF5
WO/1985/004808	A PHARMACEUTICAL PRODUCT HAVING AN ANTI-TUMOR ACTIVITY; THE USE OF A PHARMACEUTICA PRODUCT OR OF PHARMACEUTICAL COMPOSITIONS IN AN ANTI-TUMOR THERAPY

Inventors:

KRUSE ANDREW (US)
ERLANDSON SARAH (US)

Application Number:

PCT/US2021/031260

Publication Date:

February 10, 2022

Filing Date:

May 07, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

HARVARD COLLEGE (US)

International Classes:

A61K38/00; C07K16/18

Domestic Patent References:

WO2017201340A2

2017-11-23

Foreign References:

US10253083B2

2019-04-09

Other References:

DATABASE UniProtKB [online] 25 July 2006 (2006-07-25), "RecName: Full=Melanocortin receptor 4; Short=MC4-R;", XP055906476, retrieved from UniProt Database accession no. Q16317

Attorney, Agent or Firm:

ZACHARAKIS, Maria, Laccotripe et al. (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: SYSTEM AND METHOD FOR GENE AND/OR CELLULAR THERAPY

Next Patent: ELASTASE-SUBSTRATE, PEPTIDE LINKER IMMUNOCONJUGATES, AND USES THEREOF